Anixa ovarian cancer CAR-T trial advances to fifth dose cohort

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. SPY
2. NVDA
3. META
4. ONON
5. PSKY
6. VRTX
7. LGND
8. ORCL
9. USO
10. VKTX

Go back to Anixa ovarian cancer CAR-T trial advances to fifth dose cohort
(NASDAQ: ANIX) Delayed: 2.70 --0 (-0%)
Previous Close $2.70    52 Week High $ 
Open $2.73    52 Week Low $ 
Day High $2.75    P/E N/A 
Day Low $2.68    EPS $ 
Volume 134,375